enow.com Web Search

  1. Ads

    related to: cll leukemia side effects

Search results

  1. Results from the WOW.Com Content Network
  2. Cyclophosphamide - Wikipedia

    en.wikipedia.org/wiki/Cyclophosphamide

    Cyclophosphamide. Cyclophosphamide ( CP ), also known as cytophosphane among other names, [3] is a medication used as chemotherapy and to suppress the immune system. [4] As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. [4]

  3. Acalabrutinib - Wikipedia

    en.wikipedia.org/wiki/Acalabrutinib

    Acalabrutinib. Acalabrutinib, sold under the brand name Calquence, is a medication used to treat various types of non-Hodgkin lymphoma, including mantle cell lymphoma (MCL) and chronic lymphocytic leukemia /small lymphocytic Lymphoma (CLL/SLL). [7] It may be used both in relapsed as well as in treatment-naive settings.

  4. Duvelisib - Wikipedia

    en.wikipedia.org/wiki/Duvelisib

    Duvelisib is indicated to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have received at least two prior therapies that did not work or stopped working. CLL is a type of cancer that begins in the white blood cells, and SLL is a type of cancer that begins mostly in the lymph nodes.

  5. Ofatumumab - Wikipedia

    en.wikipedia.org/wiki/Ofatumumab

    Ofatumumab (Arzerra 100 mg or 1000 mg concentrate for solution for infusion) is indicated for the treatment of untreated, relapsed, or refractory chronic lymphocytic leukemia (CLL). [8] [20] [6] [21] The recommended doses for treatment of CLL are higher than MS, with 1000 or 2000 mg infusions administered monthly depending on if the CLL is ...

  6. Theralizumab - Wikipedia

    en.wikipedia.org/wiki/Theralizumab

    Theralizumab (also known as TGN1412, CD28-SuperMAB, and TAB08) is an immunomodulatory drug developed by Thomas Hünig of the University of Würzburg. It was withdrawn from development after inducing severe inflammatory reactions as well as chronic organ failure in the first-in-human study by Parexel in London in March 2006. [1]

  7. Ibrutinib - Wikipedia

    en.wikipedia.org/wiki/Ibrutinib

    Ibrutinib, sold under the brand name Imbruvica among others, is a small molecule drug that inhibits B-cell proliferation and survival by irreversibly binding the protein Bruton's tyrosine kinase (BTK). Blocking BTK inhibits the B-cell receptor pathway, which is often aberrantly active in B cell cancers. Ibrutinib is therefore used to treat such ...

  1. Ads

    related to: cll leukemia side effects